1.
van Riet BH, van Meekeren M, Fiocco M, Miah A, de Pree I, Wiltink LM, et al. Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma. AO [Internet]. 2025 Jan. 15 [cited 2026 May 16];64:69-77. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/42333